When a GLP-1 drug suppresses appetite powerfully, it addresses none of these root causes
Whether you are beginning Semaglutide, Tirzepatide, or a GLP-1 and GIP combination therapy, entering treatment with clear expectations helps reduce early side effects and enhances your overall comfort
This article examines the current evidence regarding any potential relationship between GLP-1 therapy and cortisol regulation, clarifying what these medications can and cannot achieve within UK clinical practice
Glucagon receptor activation is thought to increase energy expenditure and promote hepatic fat oxidation, potentially contributing to the substantial weight loss observed in early trials
Inflammation of the pancreas, vision changes, stomach paralysis and even death are rare but serious concerns
By prioritizing high-quality, bioavailable nutrients and a mindful lifestyle, you give your liver the tools it needs to keep you feeling your best